Results 161 to 170 of about 11,447,845 (407)

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source

Pantoprazole – safety in drug-drug interaction

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2012
The aim of review. To carry out comparative analysis of metabolic pathways of proton pump inhibitors (PPI), to determine the agent with lowest effect on activity of cytochrome CYP2C19 isoenzyme for improvement of safety of combined treatment by ...
E. V. Shikh, D. A. Sychev
doaj  

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

Molecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad, Rhiannon Newman, Elmira Khabusheva, Sofia Aakko, Eric Durand, Mahesh Tambe, Heikki Kuusanmäki, Alun Parsons, Juho J. Miettinen, Komal Kumar Javarappa, Ezgi June Olgac, Nemo Ikonen, Mika Kontro, Kimmo Porkka, Heiko Maacke, Janghee Woo, Ensar Halilovic, Caroline A. Heckman   +17 more
wiley   +1 more source

Physicians’ awareness and use of drug-drug interactions software: A preliminary study

Ibom Medical Journal
Background: Drug-drug interactions software is used as a tool to investigate clinically harmful interactions. Prescribers need to be aware of these tools to improve the quality of drug prescriptions, thus ensuring better patient care.
Oriaifo OG, Opadeyi AO, Isah AO
doaj   +1 more source

Biologically Based Complementary and Alternative Medicine Use in Breast Cancer Patients and Possible Drug-Drug Interactions

, 2023
Anna Marie Debes, Alexander Köenig, Dorothea Strobach, Timo Schinkoethe, Marie Forster, Nadia Harbeck, Rachel Wuerstlein   +6 more
openalex   +2 more sources

PHARMACOKINECTS STUDY TO EVALUATE DRUG-DRUG INTERACTIONS (DDI) BETWEEN HZN-825 AND PIRFENIDONE/NINTEDANIB [PDF]

, 2023
Yang Song, Krischan J Hudson, ZHAN YE, Wei Chen, Lisa Hawley, Jennifer Zarzoso, John Rogowski, Nicholas Siebers, GENE VOSKUHL, YAJING SUN, Y. Xin   +10 more
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Isolated conjugated hyperbilirubinemia with rifampicin and cross-reaction with rifabutin: A drug-endogenous substance interaction case report

, 2023
S. Cohen, Charlotte Devant, Laure Delaval, Caroline Charlier, Étienne Canouï, Laurent Chouchana   +5 more
openalex   +1 more source

Identifikasi Drug Related Problems (DRPs) Potensial Pada Pasien Gagal Jantung Kongestif di Instalasi Rawat Inap RSU PKU Muhammadiyah Delanggu Tahun 2016 [PDF]

, 2018
Congestive heart failure is characterized by a reduced ability of the heart pump due to changes in the structure and function of the heart. DRPs increase the risk of mortality and morbidity in patients with congestive heart failure.
, Puji Asmini, M.Sc., Apt, Nurjannah, Selvi   +1 more
core  

Drug interactions [PDF]

British Dental Journal, 2008
openaire   +2 more sources